197 related articles for article (PubMed ID: 34529714)
21. Cost-effectiveness of providing measles vaccination to all children in Guinea-Bissau.
Byberg S; Fisker AB; Thysen SM; Rodrigues A; Enemark U; Aaby P; Benn CS; Griffiths UK
Glob Health Action; 2017; 10(1):1329968. PubMed ID: 28580855
[TBL] [Abstract][Full Text] [Related]
22. [Effectiveness, population-level effects, and heath economics of measles and rubella vaccination].
Wichmann O; Ultsch B
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2013 Sep; 56(9):1260-9. PubMed ID: 23990088
[TBL] [Abstract][Full Text] [Related]
23. Cost-effectiveness of measles elimination in Latin America and the Caribbean: a prospective analysis.
Acharya A; Diaz-Ortega JL; Tambini G; de Quadros C; Arita I
Vaccine; 2002 Sep; 20(27-28):3332-41. PubMed ID: 12213403
[TBL] [Abstract][Full Text] [Related]
24. Measles vaccination of young infants in China: A cost-effectiveness analysis.
Janusz CB; Wagner AL; Masters NB; Ding Y; Zhang Y; Hutton DW; Boulton ML
Vaccine; 2020 Jun; 38(29):4616-4624. PubMed ID: 32451210
[TBL] [Abstract][Full Text] [Related]
25. Cost-effectiveness of childhood pneumococcal vaccination program in Ethiopia: results from a quasi-experimental evaluation.
Kebede TT; Svensson M; Addissie A; Trollfors B; Andersson R
BMC Public Health; 2019 Aug; 19(1):1078. PubMed ID: 31399030
[TBL] [Abstract][Full Text] [Related]
26. Challenges related to resources mobilization for measles outbreak response: Madagascar experience during the 2018-2019 measles outbreak.
Sodjinou VD; Nimpa MM; Douba A; Masembe YV; Randria M; Ndiaye CF
Pan Afr Med J; 2020; 36():304. PubMed ID: 33282087
[TBL] [Abstract][Full Text] [Related]
27. Cost-effectiveness of three different vaccination strategies against measles in Zambian children.
Dayan GH; Cairns L; Sangrujee N; Mtonga A; Nguyen V; Strebel P
Vaccine; 2004 Jan; 22(3-4):475-84. PubMed ID: 14670330
[TBL] [Abstract][Full Text] [Related]
28. Modeling the economic impact of different vial-opening thresholds for measles-containing vaccines.
Wedlock PT; Mitgang EA; Oron AP; Hagedorn BL; Leonard J; Brown ST; Bakal J; Siegmund SS; Lee BY
Vaccine; 2019 Apr; 37(17):2356-2368. PubMed ID: 30914223
[TBL] [Abstract][Full Text] [Related]
29. Cost analysis of supplemental immunization activities to deliver measles immunization to children in Anambra state, south-east Nigeria.
Sibeudu FT; Onwujekwe OE; Okoronkwo IL
Vaccine; 2020 Aug; 38(37):5947-5954. PubMed ID: 32651114
[TBL] [Abstract][Full Text] [Related]
30. Childhood immunization and age-appropriate vaccinations in Indonesia.
Chu H; Rammohan A
BMC Public Health; 2022 Nov; 22(1):2023. PubMed ID: 36333713
[TBL] [Abstract][Full Text] [Related]
31. Measles and Measles Vaccination: A Review.
Bester JC
JAMA Pediatr; 2016 Dec; 170(12):1209-1215. PubMed ID: 27695849
[TBL] [Abstract][Full Text] [Related]
32. Measles control in developing and developed countries: the case for a two-dose policy.
Tulchinsky TH; Ginsberg GM; Abed Y; Angeles MT; Akukwe C; Bonn J
Bull World Health Organ; 1993; 71(1):93-103. PubMed ID: 8440043
[TBL] [Abstract][Full Text] [Related]
33. Cost-effectiveness of maternal GBS immunization in low-income sub-Saharan Africa.
Russell LB; Kim SY; Cosgriff B; Pentakota SR; Schrag SJ; Sobanjo-Ter Meulen A; Verani JR; Sinha A
Vaccine; 2017 Dec; 35(49 Pt B):6905-6914. PubMed ID: 29129451
[TBL] [Abstract][Full Text] [Related]
34. Effects of geographic and economic heterogeneity on the burden of rotavirus diarrhea and the impact and cost-effectiveness of vaccination in Nigeria.
Anderson JD; Pecenka CJ; Bagamian KH; Rheingans RD
PLoS One; 2020; 15(5):e0232941. PubMed ID: 32469927
[TBL] [Abstract][Full Text] [Related]
35. Cost-benefit analyses of supplementary measles immunisation in the highly immunized population of New Zealand.
Hayman DTS; Marshall JC; French NP; Carpenter TE; Roberts MG; Kiedrzynski T
Vaccine; 2017 Sep; 35(37):4913-4922. PubMed ID: 28802754
[TBL] [Abstract][Full Text] [Related]
36. Impact and cost-effectiveness of measles vaccination through microarray patches in 70 low-income and middle-income countries: mathematical modelling and early-stage economic evaluation.
Fu H; Abbas K; Malvolti S; Gregory C; Ko M; Amorij JP; Jit M
BMJ Glob Health; 2023 Nov; 8(11):. PubMed ID: 37949503
[TBL] [Abstract][Full Text] [Related]
37. Effect of vaccine reminder and tracker bracelets on routine childhood immunization coverage and timeliness in urban Pakistan: protocol for a randomized controlled trial.
Siddiqi DA; Munir M; Shah MT; Khan AJ; Chandir S
BMC Public Health; 2019 Oct; 19(1):1421. PubMed ID: 31666039
[TBL] [Abstract][Full Text] [Related]
38. The Clinical Impact and Cost-effectiveness of Measles-Mumps-Rubella Vaccination to Prevent Measles Importations Among International Travelers From the United States.
Hyle EP; Fields NF; Fiebelkorn AP; Walker AT; Gastañaduy P; Rao SR; Ryan ET; LaRocque RC; Walensky RP
Clin Infect Dis; 2019 Jul; 69(2):306-315. PubMed ID: 30312374
[TBL] [Abstract][Full Text] [Related]
39. Comparing the health and social protection effects of measles vaccination strategies in Ethiopia: An extended cost-effectiveness analysis.
Driessen J; Olson ZD; Jamison DT; Verguet S
Soc Sci Med; 2015 Aug; 139():115-22. PubMed ID: 26189009
[TBL] [Abstract][Full Text] [Related]
40. Comparative Distributional Impact of Routine Immunization and Supplementary Immunization Activities in Delivery of Measles Vaccine in Low- and Middle-Income Countries.
Portnoy A; Jit M; Helleringer S; Verguet S
Value Health; 2020 Jul; 23(7):891-897. PubMed ID: 32762991
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
